Publicacions en què col·labora amb Paula Schaiquevich (18)

2024

  1. Feasibility of steroid-free tacrolimus-basiliximab immunosuppression in pediatric liver transplantation and predictors for steroid requirement

    Liver Transplantation, Vol. 30, Núm. 1, pp. 61-71

2023

  1. A pharmacometrics model to define docetaxel target in early breast cancer

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 2, pp. 727-736

  2. Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases

    Pharmaceutics, Vol. 15, Núm. 11

  3. Population pharmacokinetics of sublingually administered tacrolimus in infants and young children with liver transplantation

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 3, pp. 1115-1126

2022

  1. Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases

    Frontiers in Pharmacology, Vol. 12

2021

  1. Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy

    Epilepsia, Vol. 62, Núm. 1, pp. e7-e12

2020

  1. Clinical pharmacology of cannabidiol in refractory epilepsy

    Farmacia Hospitalaria, Vol. 44, Núm. 5, pp. 222-229

  2. Medicinal cannabis in Latin America: History, current state of regulation, and the role of the pharmacist in a new clinical experience with cannabidiol oil

    Journal of the American Pharmacists Association

2019

  1. Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America

    CPT: Pharmacometrics and Systems Pharmacology, Vol. 8, Núm. 4, pp. 197-200

  2. Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients

    Liver Transplantation, Vol. 25, Núm. 9, pp. 1397-1407

2018

  1. Survival time to biopsy-proven acute rejection and tacrolimus adverse drug reactions in pediatric liver transplantation

    Therapeutic Drug Monitoring, Vol. 40, Núm. 4, pp. 401-410

2017

  1. Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients

    International Journal of Clinical Pharmacology and Therapeutics

  2. Individualizing Dosage Regimens of Antineoplastic Agents

    Individualized Drug Therapy for Patients: Basic Foundations, Relevant Software and Clinical Applications (Elsevier Inc.), pp. 281-306

  3. Pharmacoepidemiology of tacrolimus in pediatric liver transplantation

    Pediatric Transplantation, Vol. 21, Núm. 5

  4. Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus

    Farmacia Hospitalaria, Vol. 41, Núm. 2, pp. 150-168

2016

  1. Estado de situación y regulación de laboratorios bioanalíticos que cuantifican inmunosupresores para trasplantes en Argentina

    Revista Panamericana de Salud Publica/Pan American Journal of Public Health, Vol. 39, Núm. 3, pp. 142-148

2014

  1. Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin

    International Journal of Clinical Pharmacy, Vol. 36, Núm. 4, pp. 779-786

2013

  1. Farmacovigilancia de inhibidores de calcineurina en trasplante renal y hepático pediátrico

    Farmacia Hospitalaria, Vol. 37, Núm. 6, pp. 441-449